Kypha
discovers, develops and commercializes in-vitro diagnostic biomarker tests for lupus, stroke, traumatic brain injury and kidney diseases... Read moreKypha
discovers, develops and commercializes in-vitro diagnostic biomarker tests for lupus, stroke, traumatic brain injury and kidney diseases... Read more
News
Dec 21, 2018
The Business Journals: St. Louis
Kypha: Medical diagnostics startup raises $4 million
Dec 21, 2018
THE IRISH TIMES
Kypha: Kypha raises $4m to expand capabilities of Irish subsidary Biosensia
Jul 27, 2018
The Business Journals: St. Louis
Kypha: Medical device startup Kypha raises another $950,000
Jul 16, 2018
360DX
Kypha: Biomarker-Based Dx Firm Kypha Buys Biosensia
Jul 16, 2018
The Business Journals
Kypha: Medical device startup acquires Irish diagnostics firm
Jul 16, 2018
Global FDI
Kypha: Kypha acquires Biosensia
Jul 13, 2018
StreetInsider
Press Release: Kypha : Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
May 09, 2018
The Business Journals: St. Louis
Kypha: Medical device startup raises $1.6 million
Nov 13, 2015
MEDCITY NEWS
Kypha: Kypha, startup looking to monitor inflammation quickly and accurately, raises $2.1M
Nov 13, 2015
ST. LOUIS BUSINESS JOURNAL
Kypha: Kypha raises $2.1 million in debt offering
Kypha Competitors
1
2
3
4
5
6
7
8
9
10